Bio-Rad Laboratories Share Holder Equity 2010-2025 | BIO
Bio-Rad Laboratories share holder equity from 2010 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Bio-Rad Laboratories share holder equity for the quarter ending March 31, 2025 was $6.679B, a 26.2% decline year-over-year.
- Bio-Rad Laboratories share holder equity for 2024 was $6.569B, a 24.85% decline from 2023.
- Bio-Rad Laboratories share holder equity for 2023 was $8.741B, a 9.09% decline from 2022.
- Bio-Rad Laboratories share holder equity for 2022 was $9.615B, a 29.74% decline from 2021.
| Bio-Rad Laboratories Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $6,569 |
| 2023 | $8,741 |
| 2022 | $9,615 |
| 2021 | $13,685 |
| 2020 | $9,880 |
| 2019 | $5,755 |
| 2018 | $4,020 |
| 2017 | $2,930 |
| 2016 | $2,579 |
| 2015 | $2,491 |
| 2014 | $2,185 |
| 2013 | $2,187 |
| 2012 | $2,016 |
| 2011 | $1,744 |
| 2010 | $1,541 |
| 2009 | $1,279 |
| Bio-Rad Laboratories Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $6,679 |
| 2024-12-31 | $6,569 |
| 2024-09-30 | $7,488 |
| 2024-06-30 | $6,779 |
| 2024-03-31 | $9,051 |
| 2023-12-31 | $8,741 |
| 2023-09-30 | $8,416 |
| 2023-06-30 | $8,447 |
| 2023-03-31 | $9,764 |
| 2022-12-31 | $9,615 |
| 2022-09-30 | $8,454 |
| 2022-06-30 | $8,923 |
| 2022-03-31 | $10,183 |
| 2021-12-31 | $13,685 |
| 2021-09-30 | $15,332 |
| 2021-06-30 | $11,595 |
| 2021-03-31 | $10,609 |
| 2020-12-31 | $9,880 |
| 2020-09-30 | $8,825 |
| 2020-06-30 | $7,353 |
| 2020-03-31 | $6,293 |
| 2019-12-31 | $5,755 |
| 2019-09-30 | $5,131 |
| 2019-06-30 | $5,487 |
| 2019-03-31 | $4,864 |
| 2018-12-31 | $4,020 |
| 2018-09-30 | $4,900 |
| 2018-06-30 | $4,639 |
| 2018-03-31 | $4,488 |
| 2017-12-31 | $2,930 |
| 2017-09-30 | $2,848 |
| 2017-06-30 | $2,811 |
| 2017-03-31 | $2,707 |
| 2016-12-31 | $2,579 |
| 2016-09-30 | $2,703 |
| 2016-06-30 | $2,615 |
| 2016-03-31 | $2,544 |
| 2015-12-31 | $2,491 |
| 2015-09-30 | $2,430 |
| 2015-06-30 | $2,359 |
| 2015-03-31 | $2,199 |
| 2014-12-31 | $2,185 |
| 2014-09-30 | $2,177 |
| 2014-06-30 | $2,250 |
| 2014-03-31 | $2,233 |
| 2013-12-31 | $2,187 |
| 2013-09-30 | $2,124 |
| 2013-06-30 | $2,071 |
| 2013-03-31 | $2,031 |
| 2012-12-31 | $2,016 |
| 2012-09-30 | $1,935 |
| 2012-06-30 | $1,852 |
| 2012-03-31 | $1,840 |
| 2011-12-31 | $1,744 |
| 2011-09-30 | $1,694 |
| 2011-06-30 | $1,726 |
| 2011-03-31 | $1,613 |
| 2010-12-31 | $1,541 |
| 2010-09-30 | $1,428 |
| 2010-06-30 | $1,303 |
| 2010-03-31 | $1,301 |
| 2009-12-31 | $1,279 |
| 2009-09-30 | $1,228 |
| 2009-06-30 | $1,128 |
| 2009-03-31 | $1,058 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.175B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.957B | 28.04 |
| Boston Scientific (BSX) | United States | $147.560B | 37.59 |
| Stryker (SYK) | United States | $144.011B | 30.10 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Medtronic (MDT) | Ireland | $111.928B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.49 |
| ResMed (RMD) | United States | $36.560B | 27.72 |
| Agilent Technologies (A) | United States | $33.258B | 22.04 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.84 |
| Terumo (TRUMY) | Japan | $26.680B | 34.37 |
| Insulet (PODD) | United States | $21.438B | 84.69 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.71 |
| Baxter (BAX) | United States | $15.713B | 11.81 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.31 |
| ICU Medical (ICUI) | United States | $3.250B | 24.18 |
| Envista Holdings (NVST) | United States | $3.127B | 26.73 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 19.32 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 41.46 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.81 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.71 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.80 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.55 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 5.08 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.53 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 61.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.50 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.63 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 6.12 |
| Brainsway (BWAY) | Israel | $0.206B | 55.30 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 15.33 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.37 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 48.64 |
| United-Guardian (UG) | United States | $0.037B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |